Want to see JP:3183 full AI Analyst Report?
WIN-Partners Co., Ltd. (3183) Price & Analysis
3183 Stock Chart & Stats
- Day’s Range
- JPY 1,200.00 - JPY 1,224.00
- 52-Week Range
- JPY 1,173.00 - JPY 1,527.00
- Previous Close
- JPY 1,233.00
- Volume
- 13.40K
- Average Volume (3M)
- 33.03K
- Market Cap
- JPY 34.94B
- Enterprise Value
- JPY 19.74B
- Total Cash (Recent Filing)
- JPY 15.00B
- Total Debt (Recent Filing)
- JPY 784.33M
- Price to Earnings (P/E)
- 16.5
- Beta
- 0.65
- Next Earnings
- Nov 09, 2026
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- Mar 30, 2027
- Dividend Yield
- 4.44%
Bulls Say, Bears Say
Bulls Say
Balance Sheet Strength
Extremely low leverage and sizable equity give WIN-Partners durable financial flexibility. Minimal debt reduces interest burden and supports capital allocation for dividends, investments in distribution, or absorbing shocks, enabling resilience across business cycles.
Consistent Revenue Growth
Sustained top-line momentum across multiple years indicates persistent market demand for insurance placement and advisory services. Consistent revenue growth supports scale benefits, steadier commission income and underpins predictable long-term earnings potential.
Durable Commission-based Business Model
A commission and renewal-fee model creates recurring, low-capital-intensity revenue streams. Renewal commissions and consulting fees provide ongoing cash generation and diversification across life and non-life products, supporting stable operating performance over time.
Bears Say
Cash-flow Volatility
Free cash flow swings and prior negative FCF indicate working-capital or timing sensitivity. Volatile cash conversion reduces predictability of funds for dividends, investment or M&A, and can force reliance on reserves despite reported earnings strength.
Thin And Slipping Margins
Low absolute margins and modest margin erosion limit the firm's buffer against cost rises or commission compression. Thin profitability constrains internal reinvestment and makes returns sensitive to small revenue or cost fluctuations, weakening long-term operating leverage.
Revenue Sensitivity To Distribution And Insurer Terms
Dependence on new-policy commissions, renewal rates and distributor productivity exposes revenue to sales cycles and changes in carrier commission policies. Structural shifts in distribution or insurer terms could materially affect top-line and recurring commission flows.
WIN-Partners Co., Ltd. News
3183 FAQ
What was WIN-Partners Co., Ltd.’s price range in the past 12 months?
What is WIN-Partners Co., Ltd.’s market cap?
When is WIN-Partners Co., Ltd.’s upcoming earnings report date?
How were WIN-Partners Co., Ltd.’s earnings last quarter?
Is WIN-Partners Co., Ltd. overvalued?
Does WIN-Partners Co., Ltd. pay dividends?
What is WIN-Partners Co., Ltd.’s EPS estimate?
How many shares outstanding does WIN-Partners Co., Ltd. have?
What happened to WIN-Partners Co., Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of WIN-Partners Co., Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
WIN-Partners Co., Ltd.
Established in 1973 and headquartered in Tokyo, Japan, WIN-Partners Co., Ltd. leverages its subsidiaries to distribute a comprehensive range of medical devices to healthcare institutions, primarily across Japan. Its diverse product offerings include cutting-edge cardiovascular tools such as percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters. The company also supplies devices for cardiac rhythm management, like pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters. Furthermore, WIN-Partners provides structural and peripheral vascular products, including stent grafts, transcatheter heart valves, mechanical heart valves, and various stents and embolic coils. Rounding out its portfolio are diabetes management systems such as insulin pumps and continuous glucose monitoring devices, in addition to magnetic resonance imaging equipment.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Hideumi Akizawa
- Employees
- 653
- Website
- www.win-partners.co.jp
- Address
- 2-2-1 Kyobashi, Chuo-ku, Tokyo, TY, 104-0031, JP
WIN-Partners Co., Ltd. (3183) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 3 | 5 | 14 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 0 | 0 | 12 |





